Impact of the national targeted hepatitis A immunisation program in Australia: 2000–2014. Vaccine 35, 170–176 (2017). Article PubMed Google Scholar Aggarwal, R. & Goel, A. Hepatitis A: epidemiology in resource-poor countries. Curr. Opin. Infect. Dis. 28, 488–496 (2015). Article CAS...
Nicholas A. Zwar bBernard J. Hudson a con behalf of the Travel Health Advisory Group, Australia dTravel Medicine and Infectious DiseaseLeggat PA, Zwar NA, Hudson BJ (2009) Hepatitis B risks and immunisation coverage amongst Australians travelling to south- east Asia and east Asia. Travel Med...
(Unfortunately, HBIG was inadvertently omitted from the immunisation schedule of this infant.) Transmission rates were 4/138 (3%) from HBV DNA-positive mothers overall, 4/61 (7%) from HBeAg-positive mothers, and 4/47 (9%) from mothers with very high HBV DNA levels. No transmission was ...
Irving GJ, Holden J, Yang R, Pope D (2012) Hepatitis A immunisation in persons not previously exposed to hepatitis A. Cochrane Database Syst Rev 7:CD009051 Google Scholar Download references Author information Authors and Affiliations Liver Unit, Institute of Gastroenterology and Hepatology, Jerus...
Hepatitis A is a vaccine-preventable infection caused by the hepatitis A virus (HAV). Over 150 million new infections of hepatitis A occur annually. HAV causes an acute inflammatory reaction in the liver that usually resolves spontaneously without chroni
[6] Of women with a positive record of CHB, over 97 % were overseas born. This is higher than population demographics reported by previous studies in Victoria, and more broadly within Australia, where the burden of hepatitis B is disproportionately represented by migrant and Aboriginal and ...
The history of modern research on viral hepatitis began in the year 1963, when Nobel Prize winner Baruch S. Blumberg (1925–2011) reported for the first time publicly on the discovery of a new antigen named Australia antigen (AuAg) (reference [1], page 82). In the years following, AuAg...
A., Rana, B. J., Leydon, J. & Locarnini, S. The effectiveness of the infant hepatitis B immunisation program in Fiji, Kiribati, Tonga and Vanuatu. Vaccine 18, 3059–3066 (2000). CAS PubMed Google Scholar McMahon, B. J. Viral hepatitis in the Arctic. Int. J. Circumpolar Health ...
A medical librarian refined the search strategy. Detailed search records for each database are shown in Supplementary material 1. Study screening After removing duplicates using Covidence (Veritas Health Innovation, Melbourne, Australia), four researchers independently screened the titles and abstracts of ...
GAVI was one of the organisations that supported universal hepatitis B immunisation of infants in China. In addition, organisations such as GAVI, which recently announced prioritised investment in HBV birth-dose vaccines, can make a tremendous difference with raising awareness particularly through ...